Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00582348
Official study title

Physical Activity and Inactivity in Lung Cancer Survivors

Study summary

The purpose of this study is to learn how often lung cancer survivors exercise. We also want to learn what helps people to be active or prevents them from being active. Learning this will help us to expand services for lung cancer survivors.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedNot specified

The study team can explain what participation involves.

Who it may be forLung Cancer Survivors

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 12, 2020 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Not specified
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Diagnosis of primary Stage IA or IB NSCLC;
  • Underwent surgical resection for NSCLC at MSKCC;
  • From 1 to 5 years post-treatment for NSCLC prior to study recruitment;
  • No evidence of disease (NED) at the time of recruitment;
  • Can be reached by telephone;
  • Able to provide informed consent.
Reasons someone may not be able to joinExclusion criteria
  • Undergoing active antineoplastic treatment;
  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Memorial Sloan-Kettering Cancer CenterNew York, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 12, 2020. Always confirm current availability with the study team.

View original record ↗